SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001016169-09-000061
Filing Date
2009-11-09
Accepted
2009-11-09 16:13:26
Documents
3
Period of Report
2009-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 nov8k.htm 8-K 25790
2 PRESS RELEASE, DATED NOVEMBER 9, 2009 pressrelease.htm EX-99.1 140985
3 logo.jpg GRAPHIC 8890
  Complete submission text file 0001016169-09-000061.txt   180975
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 091168562
SIC: 3841 Surgical & Medical Instruments & Apparatus